{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:16:00Z","timestamp":1792156560654,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"UTHSA IIMS-CTSA","award":["UL1 TR001120"],"award-info":[{"award-number":["UL1 TR001120"]}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01-DK80157"],"award-info":[{"award-number":["R01-DK80157"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01-DK089229"],"award-info":[{"award-number":["R01-DK089229"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["7-13-GSK-01"],"award-info":[{"award-number":["7-13-GSK-01"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"name":"San Antonio Claude D. Pepper Older Americans Independence Center","award":["P30 AG044271"],"award-info":[{"award-number":["P30 AG044271"]}]},{"name":"San Antonio Nathan Shock Center of Excellence in the Biology of Aging","award":["P30 AG021890"],"award-info":[{"award-number":["P30 AG021890"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.exger.2017.12.026","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T12:31:51Z","timestamp":1517661111000},"page":"53-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"special_numbering":"C","title":["A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects"],"prefix":"10.1016","volume":"105","author":[{"given":"Ellen","family":"Kraig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry Q.","family":"Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana D.","family":"Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Javors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Musi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Chiodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Koek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.L.","family":"Gelfond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Dean L.","family":"Kellogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2017.12.026_bb0005","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/gerona\/glw090","article-title":"Rapamycin: an InhibiTOR of aging emerges from the soil of Easter Island","volume":"71","author":"Apelo","year":"2016","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.exger.2017.12.026_bb0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/acel.12405","article-title":"Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system","volume":"15","author":"Apelo","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2017.12.026_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exger.2017.12.026_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2011.08.006","article-title":"TOR in the immune system","volume":"23","author":"Araki","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.exger.2017.12.026_bb0025","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/TP.0b013e318184112c","article-title":"Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma","volume":"86","author":"Barozzi","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.exger.2017.12.026_bb0030","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.4049\/jimmunol.180.9.5794","article-title":"Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin","volume":"180","author":"Basu","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0035","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+ CD25+ FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053078","article-title":"Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study","volume":"8","author":"Buron","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exger.2017.12.026_bb0045","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1172\/JCI43873","article-title":"Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice","volume":"120","author":"Chen","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exger.2017.12.026_bb0050","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3390\/ijms18071494","article-title":"Rapamycin maintains the chondrocytic phenotype and interferes with inflammatory cytokine induced processes","volume":"18","author":"De Luna-Preitschopf","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exger.2017.12.026_bb0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0060","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.transproceed.2008.03.084","article-title":"Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials","volume":"40","author":"Demopoulos","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.exger.2017.12.026_bb0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/1078-0432.CCR-14-3239","article-title":"Molecular pathways: increased susceptibilityto infection is a complication of mTOR inhibitor use in cancer therapy","volume":"22","author":"Eiden","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.exger.2017.12.026_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coi.2010.10.010","article-title":"Role of autophagy in the host response to microbial infection and potential for therapy","volume":"23","author":"Fabri","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/acel.12280","article-title":"Lifespan extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms","volume":"14","author":"Goldberg","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2017.12.026_bb0080","article-title":"A New, Quick and Cost Effective Coding Test: The Texas Assessment of Processing Speed (TAPS)","volume":"71","author":"Grosch","year":"2012"},{"key":"10.1016\/j.exger.2017.12.026_bb0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exger.2017.12.026_bb0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/152692480401400410","article-title":"Influenza vaccine antibody responses in lung transplant recipients","volume":"14","author":"Hayney","year":"2004","journal-title":"Prog. Transplant."},{"key":"10.1016\/j.exger.2017.12.026_bb0095","article-title":"Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells","volume":"6","author":"He","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exger.2017.12.026_bb0100","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/acel.12380","article-title":"Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune\u2013deficient mice","volume":"14","author":"Hurez","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2017.12.026_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nm.1928","article-title":"Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells","volume":"15","author":"Jagannath","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.exger.2017.12.026_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.267pe25","article-title":"Immune regulation by rapamycin: moving beyond T cells","volume":"2","author":"Janes","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.exger.2017.12.026_bb0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1365-3083.2001.00862.x","article-title":"Sirolimus interferes with the innate response to bacterial products in human whole blood by attenuation of IL-10 production","volume":"53","author":"J\u00f8rgensen","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1399-0012.2000.140201.x","article-title":"Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity","volume":"14","author":"Kahana","year":"2000","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.exger.2017.12.026_bb0125","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/j.1600-6143.2011.03753.x","article-title":"Influenza vaccination in the organ transplant recipient: review and summary recommendations","volume":"11","author":"Kumar","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.exger.2017.12.026_bb0130","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/acel.12097","article-title":"Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive","volume":"12","author":"Lamming","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2017.12.026_bb0135","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.transproceed.2009.08.050","article-title":"Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement","volume":"41","author":"Lang","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.exger.2017.12.026_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/acel.12524","article-title":"Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways","volume":"16","author":"Lesniewski","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2017.12.026_bb0145","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","article-title":"Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease","volume":"33","author":"Lin","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.exger.2017.12.026_bb0150","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ni.1939","article-title":"The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells","volume":"11","author":"Liu","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0155","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1474-9726.2011.00791.x","article-title":"Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling","volume":"11","author":"Majumder","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2017.12.026_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exger.2017.12.026_bb0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1139\/y77-007","article-title":"Inhibition of the immune response by rapamycin a new antifungal antibiotic","volume":"55","author":"Martell","year":"1976","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.exger.2017.12.026_bb0170","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exger.2017.12.026_bb0175","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.exger.2017.12.026_bb0180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/gerona\/glq178","article-title":"Rapamycin but not resveratrol or simvastatin, extends life span of genetically heterogenous mice","volume":"66","author":"Miller","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.exger.2017.12.026_bb0185","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/acel.12194","article-title":"Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction","volume":"13","author":"Miller","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2017.12.026_bb0190","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.drudis.2015.05.006","article-title":"Sirolimus and everolimus in kidney transplantation","volume":"20","author":"Moes","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.exger.2017.12.026_bb0195","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.4049\/jimmunol.1102133","article-title":"Rapamycin attenuates airway hyperreactivity, goblet cells, and IgE in experimental asthma","volume":"187","author":"Mushaben","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2249.2008.03780.x","article-title":"Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin","volume":"155","author":"Nicoletti","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.intimp.2004.09.008","article-title":"Decreased Cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients","volume":"5","author":"Ozaki","year":"2005","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.exger.2017.12.026_bb0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4062\/biomolther.2012.20.1.043","article-title":"Destabilization of TNF-\u03b1 mRNA by rapamycin","volume":"20","author":"Park","year":"2012","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.exger.2017.12.026_bb0215","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1681\/ASN.2008050474","article-title":"Diabetes after transplantation and sirolimus: what's the connection?","volume":"19","author":"Pavlakis","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.exger.2017.12.026_bb0220","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00125-010-1959-6","article-title":"Beta cell function during rapamycin monotherapy in long term type 1 diabetes","volume":"54","author":"Piemonti","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.exger.2017.12.026_bb0225","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/0961203307081401","article-title":"Prevention of lupus in NZBxW mice by sirolimus","volume":"16","author":"Ramos-Barron","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.exger.2017.12.026_bb0230","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.4161\/cc.9.15.12359","article-title":"Fine-tuning CD8(+) T cell functional responses: mTOR acts as a rheostat for regulating CD8(+) T cell proliferation, survival and differentiation?","volume":"9","author":"Rao","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exger.2017.12.026_bb0235","doi-asserted-by":"crossref","first-page":"964","DOI":"10.18632\/aging.100843","article-title":"Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus)","volume":"7","author":"Ross","year":"2015","journal-title":"Aging"},{"key":"10.1016\/j.exger.2017.12.026_bb0240","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1532-5415.1992.tb03646.x","article-title":"Bedside assessment of executive cognitive impairment: the executive interview","volume":"40","author":"Royall","year":"1992","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.exger.2017.12.026_bb0245","first-page":"141","article-title":"Th1, Th2 and Th17 cytokine profile in patients with multiple sclerosis following treatment with rapamycin","volume":"13","author":"Salehi","year":"2016","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0250","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11523-009-0107-z","article-title":"The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents","volume":"4","author":"Sankhala","year":"2009","journal-title":"Target. Oncol."},{"key":"10.1016\/j.exger.2017.12.026_bb0255","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/ndt\/gfp674","article-title":"Anaemia, microcytosis and sirolimus\u2014is iron the missing link?","volume":"25","author":"Sofroniadou","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.exger.2017.12.026_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005994","article-title":"Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin","volume":"4","author":"Strauss","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exger.2017.12.026_bb2005","doi-asserted-by":"crossref","first-page":"e32497","DOI":"10.7554\/eLife.32497","article-title":"A population of innate myelolyphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice","volume":"6","author":"Tang","year":"2017","journal-title":"eLIFE"},{"key":"10.1016\/j.exger.2017.12.026_bb0265","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/gerona\/glu101","article-title":"Testing efficacy of administration of the antiaging drug rapamycin in a nonhuman primate, the common marmoset","volume":"70","author":"Tardif","year":"2014","journal-title":"J. Gerontol."},{"key":"10.1016\/j.exger.2017.12.026_bb0270","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.JGP.0000221510.33817.86","article-title":"Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder-a pilot study","volume":"14","author":"Tariq","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.exger.2017.12.026_bb0275","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood-2006-01-010124","article-title":"Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)","volume":"108","author":"Teachey","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exger.2017.12.026_bb0280","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/pbc.22183","article-title":"Treatment with sirolimus ameliorates tacrolimus-induced autoimmune cytopenias after solid organ transplant","volume":"53","author":"Teachey","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.exger.2017.12.026_bb0285","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0290","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0009-9120(98)00048-4","article-title":"Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update","volume":"31","author":"Trepanier","year":"1998","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.exger.2017.12.026_bb0295","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1600-6143.2010.03407.x","article-title":"Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques","volume":"11","author":"Turner","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.exger.2017.12.026_bb0300","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11357-017-9972-z","article-title":"A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs","volume":"39","author":"Urfer","year":"2017","journal-title":"GeroScience"},{"key":"10.1016\/j.exger.2017.12.026_bb0305","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.it.2009.02.002","article-title":"The multiple facets of mTOR in immunity","volume":"30","author":"Weichhart","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.exger.2017.12.026_bb0310","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1474-9726.2012.00832.x","article-title":"Rapamycin slows aging in mice","volume":"11","author":"Wilkinson","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2017.12.026_bb0315","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1600-6143.2007.01869.x","article-title":"The effect of sirolimus therapy on vaccine responses in transplant recipients","volume":"7","author":"Willcocks","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.exger.2017.12.026_bb0320","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ki.1993.251","article-title":"CsA, FK506, corticosteroids and rapamycin inhibit TNF\u03b1 production by cultured PTEC","volume":"44","author":"Yard","year":"1993","journal-title":"Kidney Int."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556517309130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556517309130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T02:26:41Z","timestamp":1759976801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556517309130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":65,"alternative-id":["S0531556517309130"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2017.12.026","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2017.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}